. Société-française, Mésusage de l'alcool. Dépistage, diagnostic et traitementRecommandation de bonne pratique, Alcoologie Addictologie, vol.37, issue.1, pp.5-84, 2015.

B. Roehr, American Psychiatric Association explains DSM-5, BMJ, vol.346, p.3591, 2013.

D. A. Regier, E. A. Kuhl, and D. J. Kupfer, The DSM-5: Classification and criteria changes, World Psychiatry, vol.12, issue.2, pp.92-98, 2013.

, American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders : Fifth Edition, DMS Library, 2013.

, World Health Organization. International guide for monitoring alcohol consumption and related harm, 2000.

. Disponible,

. Disponible,

I. , Alcool et santé : bilan et perspectives

F. Beck and J. Richard, La consommation d'alcool en France. Presse Médicale, vol.43, pp.1067-79, 2014.

S. Guerin, A. Laplanche, A. Dunant, and C. Hill, Alcohol-attributable mortality in France, Eur J Public Health. 1 août, vol.23, issue.4, pp.588-93, 2013.

F. Saint-maurice and L. Møller, Numéro thématique-L'alcool, toujours un facteur de risque majeur pour la santé en France Special issue-Alcohol remains a major risk factor for health in France

. Disponible,

M. Pousset and J. Ades, Observatoire Français des Drogues et des Toxicomanies, Paris. FRA. Drogues, chiffres clés. 5e édition, p.8, 2013.

, All in for alcohol awareness, Lancet Lond Engl. 18 avr, vol.385, issue.9977, p.1477, 2015.

M. B. Esser, S. L. Hedden, D. Kanny, R. D. Brewer, J. C. Gfroerer et al., Prevalence of alcohol dependence among US adult drinkers, Prev Chronic Dis, vol.11, p.206, 2009.

, Observatoire Français des Drogues et des Toxicomanies. (O.F.D.T.). Paris. FRA. Drogues et addictions, données essentielles, p.399, 2013.

N. L. Cooney, M. D. Litt, J. L. Cooney, D. T. Pilkey, H. R. Steinberg et al., Concurrent brief versus intensive smoking intervention during alcohol dependence treatment, Psychol Addict Behav J Soc Psychol Addict Behav. déc, vol.21, issue.4, pp.570-575, 2007.

K. B. Friend and M. E. Pagano, Smoking initiation among nonsmokers during and following treatment for alcohol use disorders, J Subst Abuse Treat. avr, vol.26, issue.3, pp.219-243, 2004.

T. R. Franklin, D. Harper, K. Kampman, S. Kildea-mccrea, J. W. Lynch et al., The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study, Drug Alcohol Depend. 1 juill, vol.103, issue.1-2, pp.30-36, 2009.

U. Frischknecht, T. Sabo, and K. Mann, Improved drinking behaviour improves quality of life: a follow-up in alcohol-dependent subjects 7 years after treatment, Alcohol Alcohol, vol.48, issue.5, pp.579-84, 2013.

R. L. Picci, F. Oliva, M. Zuffranieri, P. Vizzuso, L. Ostacoli et al., Quality of life, alcohol detoxification and relapse: is quality of life a predictor of relapse or only a secondary outcome measure?, Qual Life Res Int J Qual Life Asp Treat Care Rehabil. déc, vol.23, issue.10, pp.2757-67, 2014.

, Le Craving : approche transversale, dimensionnelle et translationnelle | Congrès Français de Psychiatrie

A. R. Childress, T. R. Franklin, J. Listerud, P. Acton, O. Brien et al., Neuroimaging of cocaine craving states: cessation, stimulant administration, and drug cue paradigms, Neuropsychopharmacol Fifth Gener Prog ACNP, vol.110, pp.1575-90, 2002.

W. Ling, S. Shoptaw, and D. Majewska, Baclofen as a Cocaine Anti-Craving Medication: A Preliminary Clinical Study, Neuropsychopharmacology. mai, vol.18, issue.5, pp.403-407, 1998.

D. Roberts, M. M. Andrews, and G. J. Vickers, Baclofen attenuates the reinforcing effects of cocaine in rats, Neuropsychopharmacology, vol.15, issue.4, pp.417-440, 1996.

D. C. Roberts and M. M. Andrews, Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure, Psychopharmacology (Berl). juin, vol.131, issue.3, pp.271-278, 1997.

S. M. Kim, D. H. Han, K. J. Min, B. Kim, and J. H. Cheong, Brain activation in response to cravingand aversion-inducing cues related to alcohol in patients with alcohol dependence, Drug Alcohol Depend. 1 août, vol.141, pp.124-155, 2014.

A. Koopmann, T. Leménager, N. D. Wolf, R. I. Hermann, D. Koch et al., The impact of atrial natriuretic peptide on anxiety, stress and craving in patients with alcohol dependence, Alcohol Alcohol. juin, vol.49, issue.3, pp.282-288, 2014.

R. Sinha, H. C. Fox, K. Hong, J. Hansen, K. Tuit et al., Effects of adrenal sensitivity, stress-and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes, Arch Gen Psychiatry. sept, vol.68, issue.9, pp.942-52, 2011.

G. Addolorato, L. Leggio, S. Cardone, A. Ferrulli, and G. Gasbarrini, Role of the GABA(B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives, Alcohol Fayettev N, vol.43, issue.7, pp.559-63, 2009.

L. Leggio, W. H. Zywiak, S. R. Fricchione, S. M. Edwards, S. M. De-la-monte et al., Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation, Biol Psychiatry, vol.76, issue.9, pp.734-775, 2014.

M. Bottlender and M. Soyka, Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment, Alcohol Alcohol. août, vol.39, issue.4, pp.357-61, 2004.

O. Ameisen, Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician, Alcohol Alcohol. avr, vol.40, issue.2, pp.147-50, 2005.

K. Journiac, F. Pascuttini, and D. Touzeau, La saga du baclofène et le changement de paradigme de la prise en charge de l'addiction à l'alcool. Presse Médicale, vol.45, pp.1117-1140, 2016.

W. Bucknam, Suppression of symptoms of alcohol dependence and craving using highdose baclofen, Alcohol Alcohol. avr, vol.42, issue.2, pp.158-60, 2007.

G. Addolorato, L. Leggio, A. Ferrulli, S. Cardone, G. Bedogni et al., Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial, Alcohol Alcohol. juin, vol.46, issue.3, pp.312-319, 2011.

L. Rigal, C. Alexandre-dubroeucq, R. De-beaurepaire, L. Jeunne, C. Jaury et al., Abstinence and « low-risk » consumption 1 year after the initiation of high-dose baclofen: a retrospective study among « high-risk » drinkers, Alcohol Alcohol. août, vol.47, issue.4, pp.439-481, 2012.

O. Ameisen and R. De-beaurepaire, Suppression de la dépendance à l'alcool et de la consommation d'alcool par le baclofène à haute dose : un essai en ouvert, Ann MédPsychol Rev Psychiatr. mars, vol.168, issue.2, pp.159-62, 2010.

G. M. Dore, K. Lo, L. Juckes, S. Bezyan, and N. Latt, Clinical Experience with Baclofen in the Management of Alcohol-Dependent Patients with Psychiatric Comorbidity: A Selected Case Series, Alcohol Alcohol, vol.46, issue.6, pp.714-734, 2011.

R. De-beaurepaire, Suppression of Alcohol Dependence Using Baclofen: A 2-Year Observational Study of 100 Patients. Front Psychiatry, vol.3, 2017.

R. De-beaurepaire, The Use of Very High-Doses of Baclofen for the Treatment of AlcoholDependence: A Case Series. Front Psychiatry, vol.5, 2014.

L. Rigal, L. Hoang, L. , A. , C. Pinot et al., Tolerability of High-dose Baclofen in the Treatment of Patients with Alcohol Disorders: A Retrospective Study, Alcohol Alcohol. sept, vol.50, issue.5, pp.551-558, 2015.

P. Gache and . Baclofène, Vérités et promesses d'un "nouveau" venu dans le traitement de l'alcoolo-dépendance, Alcoologie Addictologie. 15 juin, vol.32, issue.2, pp.119-143, 2010.

G. Addolorato, L. Leggio, A. Ferrulli, S. Cardone, L. Vonghia et al., Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study, Lancet Lond Engl. 8 déc, vol.370, issue.9603, pp.1915-1937, 2007.

A. European-medicines, Guideline on the development of medicinal products for the treatment of alcohol dependence, 2010.

D. Raistrick, N. Heather, and C. Godfrey, Review of the effectiveness of treatment for alcohol problems, 2006.

A. S. Zigmond and R. P. Snaith, The hospital anxiety and depression scale, Acta Psychiatr Scand. juin, vol.67, issue.6, pp.361-70, 1983.

J. P. Lépine, M. Godchau, P. Brun, and T. Lempérière, Evaluation of anxiety and depression among patients hospitalized on an internal medicine service, Ann Méd-Psychol. févr, vol.143, issue.2, pp.175-89, 1985.

C. Brennan, A. Worrall-davies, D. Mcmillan, S. Gilbody, and A. House, The Hospital Anxiety and Depression Scale: a diagnostic meta-analysis of case-finding ability, J Psychosom Res, vol.69, issue.4, pp.371-379, 2010.

R. F. Anton, D. H. Moak, and P. Latham, The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior, Alcohol Clin Exp Res. févr, vol.19, issue.1, pp.92-101, 1995.

J. M. Chignon, L. Jacquesy, M. Mennad, A. Terki, F. Huttin et al., Self-assessment questionnaire of alcoholic craving (ECCA Questionnaire: Behavior and Cognition in Relation to Alcohol: French translation and validation of the Obsessive-Compulsive Drinking Scale. L'Encéphale, vol.24, pp.426-460, 1998.

A. Leplège, E. Ecosse, A. Verdier, and T. V. Perneger, The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation, J Clin Epidemiol, vol.51, issue.11, pp.1013-1036, 1998.

, Niveaux de formation?Tableaux de l'Économie Française | Insee, 2017.

. Fiches-activité, chômage, revenus du travail-Insee RéférencesÉdition 2016?Emploi, chômage, revenus du travail | Insee

. Disponible,

, Évolution de la population?Bilan démographique 2016 | Insee, 2017.

, État matrimonial légal des personnes selon le sexe en 2016 | Insee, 2017.

M. Reynaud, H. Aubin, F. Trinquet, B. Zakine, C. Dano et al., Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study, Alcohol Alcohol Oxf Oxfs. 1 juill, vol.52, issue.4, pp.439-485, 2017.

E. M. Beraha, E. Salemink, A. E. Goudriaan, A. Bakker, D. De-jong et al., Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial, Eur Neuropsychopharmacol. déc, vol.26, issue.12, pp.1950-1959, 2016.

C. A. Müller, O. Geisel, P. Pelz, V. Higl, J. Krüger et al., High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial, Eur Neuropsychopharmacol. 1 août, vol.25, issue.8, pp.1167-77, 2015.

. Résumé-du-protocole-bacloville, , 2017.

, Pendant quelle durée maximale avez-vous été abstinent ? ??????? mois ??????? années

, Quand cette période a-t-elle débuté ? ???????/?????????????

M. M/-a-a-a-a, Selon vous, qu'est-ce qui vous a permis d'atteindre ce résultat ? ??????????

?. .. ?????????????????, . ???????????, and . ?????????????????,

, Nous allons maintenant vous poser des questions sur votre suivi médical